Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER × PT2385 × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 851 Radiotherapy 763 Cisplatin 657 Gemcitabine 583 Docetaxel 538 Carboplatin 538 Paclitaxel 529 Bevacizumab 513 Fluorouracil 452 Rituximab 412 Oxaliplatin 405 Capecitabine 400 Surveys and Questionnaires 391 Dexamethasone 388 Doxorubicin 381 Etoposide 367 Irinotecan 351 Cytarabine 333 Filgrastim 330 pembrolizumab 277 Leucovorin 277 Melphalan 266 fludarabine phosphate 261 Magnetic Resonance Spectroscopy 259 Nivolumab 254 Blood Specimen Collection 251 Lenalidomide 244 Peripheral Blood Stem Cell Transplantation 242 Methotrexate 239 Cetuximab 236

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03216499 2022-05-09

PT2385

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed

24 enrolled 11 charts

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡